Trial intelligence / Profile preview

Passiflora monotherapy for adults with anxiety in pharmaceutical care

RBR-6fhv7x5Phase 4Not yet recruiting

Sponsor
Federal University of Alfenas
Start
Oct 2023
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of passiflora incarnata in anxiety disorder, sponsored by Federal University of Alfenas. Planned start Oct 2023; status: not yet recruiting.

02

Drugs

passiflora incarnata
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on RBR-6fhv7x5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6fhv7x5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call